EGFR and liver cancer: The epidermal growth factor receptor (EGFR) has been found to be overexpressed or hyperactivated in the cancer cells of most liver cancer patients as well as be the reason for continuous activation of its downstream signaling of the Ras/Raf/MEK/ERK pathway.